Nova Eye Medical Limited
Nova Eye Medical Limited (ELXMF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
elxmf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Nova Eye Medical Limited (ELXMF) measures how much investors pay for each dollar of the company's trailing earnings. ELXMF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%11.8x
MedianQ3 · 75%41.3x
Max
At N/A, ELXMF's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Nova Eye Medical LimitedYou ELXMF | $1M | N/A | — | -$0.02 |
 Alternate Health Corp. AHGIF | $0M | N/A | — | -$0.44 |
 Ecofibre Limited EOFBF | $0M | N/A | — | -$0.12 |
 ImpediMed Limited IPDQF | $11M | N/A | — | -$0.01 |
 Novacyt S.A. NVYTF | $35M | N/A | — | -$0.33 |
 Next Science Limited NXSCF | $0M | N/A | — | -$0.04 |
 PetVivo Holdings, Inc. PETV | $22M | N/A | — | -$0.41 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.04 | — | |
2024-06-30 FY2024 | — | $-0.04 | — | |
2023-06-30 FY2023 | — | $-0.10 | — | |
2022-06-30 FY2022 | — | $-0.05 | — | |
2021-06-30 FY2021 | — | $-0.03 | — | |
2020-06-30 FY2020 | — | $-0.05 | — | |
2019-06-30 FY2019 | — | $-0.05 | — | |
2018-06-30 FY2018 | — | $-0.04 | — | |
2017-06-30 FY2017 | — | $-0.01 | — | |
2016-06-30 FY2016 | 37.05x | $0.03 | +53.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Nova Eye Medical Limited (ELXMF) measures how much investors pay for each dollar of the company's trailing earnings. ELXMF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.
Frequently asked questions
ELXMF pe ratio · 6 questionsELXMF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via ELXMF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nova Eye Medical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09